A RAIR–ATC transcriptional axis and multimodal drug-response modelling reveal class-level vulnerabilities in thyroid cancer
Abstract Introduction: Radioiodine-refractory papillary thyroid carcinoma (RAIR PTC) and anaplastic thyroid carcinoma (ATC) are clinically challenging thyroid cancer states, yet…